|
Monday, 08/02/2010
|
Cancer Marker Identification via Penalized Integrative Analysis
Shuangge Ma, Yale University
|
Doing Better Than Average: Tailored Therapeutics in Drug Development
Stan Young, National Institute for Statistical Science; Stephen J. Ruberg, Eli Lilly and Company; Frank Rockhold, GlaxoSmithKline; Sue-Jane Wang, FDA; Stephen Senn, University of Glasgow
1:00 AM
|
Risk Predictions from Genomewide Association Data
Hongyu Zhao, Yale University; Jia Kang, Yale University; Ruiyan Luo, Yale University; Judy Cho, Yale University
8:35 AM
|
Future Directions in the Analysis of Genomic Data
Nancy Zhang, Stanford University; Terence (Terry) Paul Speed, Walter & Eliza Hall Institute of Medical Research
8:35 AM
|
Discriminating Between Microbial Populations
Frederick A. Matsen, Fred Hutchinson Cancer Research Center ; Steven N. Evans, University of California, Berkeley
9:35 AM
|
Large-Margin, Single-Path Hierarchical Classification with a General Loss
Lingzhou Xue, University of Minnesota; Xiaotong Shen, University of Minnesota
9:55 AM
|
Joint Inference of Sparse Network and Genetic Association in Genetical Genomics Studies
Hongzhe Li, University of Pennsylvania
11:00 AM
|
Learning Regulatory Network from Multiple Genomics Array Data
Pei Wang, Fred Hutchinson Cancer Research Center; Jie Peng, University of California, Davis
11:25 AM
|
Statistical Analysis of Somatic Changes in Cancer Genomics
Giovanni Parmigiani, Harvard University
11:25 AM
|
Some Statistical Issues in the Analysis of High-Throughput Sequencing Data
Margaret Taub, The Johns Hopkins University
2:05 PM
|
Modeling with Pairwise Comparisons
Jeffrey Leek, Johns Hopkins Bloomberg School of Public Health; Leslie Cope, The Johns Hopkins University; Donald Geman, The Johns Hopkins University; Giovanni Parmigiani, Harvard University
2:05 PM
|
Integration of Genomic Data to Infer the Genetic Architecture of Complex Phenotypes
Sayan Mukherjee, Duke University; Qing Xiong, Duke University; Terrence Furey, Duke University
2:30 PM
|
Overcoming the Winner's Curse to Identify Biomarkers with Clinical Relevance in Drug Development
Lei Shen, Eli Lilly and Company; Haoda Fu, Eli Lilly and Company
3:20 PM
|
|
Wednesday, 08/04/2010
|
Bayesian Methods in Genomics: Searching for Unity in Diverse Data Sources
Bhramar Mukherjee, University of Michigan; Debashis Ghosh, Pennsylvania State University
|
Genomics in the Pharmaceutical Industry: Where Is It Headed?
Dhammika Amaratunga, Johnson & Johnson; James Colaianne, Johnson & Johnson
|
Statistics, Technology, Epigenomics, and Our Future
Rebecca W. Doerge, Purdue University; Paul Auer, Purdue University
10:35 AM
|
Efficient Exploration of Multiple ChIP-seq and ChIP-chip Data Sets
Hongkai Ji, The Johns Hopkins University
2:35 PM
|
Critiquing Bioinformatics Resources When ID Mapping Is Needed to Integrate Genomic and Proteomic Studies
Roger Day, University of Pittsburgh; Kevin McDade, University of Pittsburgh; Uma Chandran, University of Pittsburgh; Alex Lisovich, University of Pittsburgh
3:20 PM
|
|
Thursday, 08/05/2010
|
Biomarkers in Clinical Trials in the Development of Biologics and Risk Assessment
Samir Lababidi, FDA
8:50 AM
|
A Penalized Matrix Decomposition, with Applications to Sparse Principal Components and Canonical Correlation Analysis
Daniela Witten, Stanford University; Rob Tibshirani, Stanford University; Trevor Hastie, Stanford University
9:25 AM
|
P-Values or Prediction Errors: What Is the Name of the Game in Genomics?
Rafal Kustra, University of Toronto
9:35 AM
|
A Robust Statistical Framework for eQTL Analysis
Mohamedou Sow, Samuel Lunenfeld Research Institute; Gilles Durrieu, University Bordeaux 1; Laurent Briollais, Samuel Lunenfeld Research Institute
10:50 AM
|
|